Incorporating Whole-Genome Sequencing into Public Health Surveillance: Lessons from Prospective Sequencing of Salmonella Typhimurium in Australia

Abstract

In Australia, the incidence of Salmonella Typhimurium has increased dramatically over the past decade. Whole-genome sequencing (WGS) is transforming public health microbiology, but poses challenges for surveillance. To compare WGS-based approaches with conventional typing for Salmonella surveillance, we performed concurrent WGS and multilocus variable-number tandem-repeat analysis (MLVA) of Salmonella Typhimurium isolates from the Australian Capital Territory (ACT) for a period of 5 months. We exchanged data via a central shared virtual machine and performed comparative genomic analyses. Epidemiological evidence was integrated with WGS-derived data to identify related isolates and sources of infection, and we compared WGS data for surveillance with findings from MLVA typing. We found that WGS data combined with epidemiological data linked an additional 9% of isolates to at least one other isolate in the study in contrast to MLVA and epidemiological data, and 19% more isolates than epidemiological data alone. Analysis of risk factors showed that in one WGS-defined cluster, human cases had higher odds of purchasing a single egg brand. While WGS was more sensitive and specific than conventional typing methods, we identified barriers to uptake of genomic surveillance around complexity of reporting of WGS results, timeliness, acceptability, and stability. In conclusion, WGS offers higher resolution of Salmonella Typhimurium laboratory surveillance than existing methods and can provide further evidence on sources of infection in case and outbreak investigations for public health action. However, there are several challenges that need to be addressed for effective implementation of genomic surveillance in Australia.

Optimizing open data to support one health: best practices to ensure interoperability of genomic data from bacterial pathogens

“…First, the advent of whole genome sequencing (WGS) made it possible to establish genomic DNA as a standard data type and increase the resolution possible between isolates, dramatically changing how surveillance data for human pathogens could be stored, shared, and analyzed [1]. Second, storing and sharing genomic pathogen data and surveillance analyses as "open data" [2] has enabled a truly open vision for all global pathogen surveillance, as shown by the success of the open foodborne pathogen surveillance model in the United States [2][3][4] and in partnering countries, such as the United Kingdom [5], Australia [6,7], Mexico [8,9], and Canada [10,11]. Newer open surveillance efforts for health care acquired illness (HAI) [10][11][12] and viral diseases [13,14] are on a similar trajectory for success.…”

Perceived utility and feasibility of pathogen genomics for public health practice: a survey among public health professionals working in the field of infectious diseases, Belgium, 2019

“…Familiarity with sequencing technologies and pathogen genomics varied between the different professional groups, with data providers being more familiar than data end-users. As shown before, one of the largest barriers to acceptability from the public health unit is the capacity to understand and use the data [ 50 ]. Possibly, there is a positive association between genomic literacy and (critically) predicting the added value in public health.…”

Antimicrobial resistance surveillance with whole genome sequencing in Africa: It’s (about) time

“…When it was conceived, it faced big challenges, ranging from scepticism that laboratory data were comparable across countries to doubts about the usefulness of comparing data from countries with vastly different healthcare systems and diagnostic practices. 4 In the end, EARS-Net has robust participation across all European Union member states and has become a strong advocacy tool for antibiotic policy. The idea of EARS-Net was inspired by a ready supply of relatively reliable results from antibiotic susceptibility tests that were conducted routinely in the course of patient care.…”